TrialSite News profiled Moderna back in December, 2018. Recently, they reported a dosing of the first subject in a Phase 1 clinical trial evaluating the safety and tolerability of escalating doses of mRNA-1944 via intravenous infusion in healthy adults.  The sponsor...